ALFA Filings
Every announcement, straight from the exchange
Every Persistent Systems other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
10 announcements with these filters
Persistent Systems approved audited financial statements for the quarter and half year ended September 30, 2026. The documents are available on the company website.
Persistent Systems amended Article 12(iii) of its Articles of Association regarding the "Further Issue of Shares", as approved by the company's members.
Persistent Systems has received an 'Excellent' ESG rating of 71 from ESG Risk Assessment & Insights Limited for the fiscal year 2025-26.
Persistent Systems approved its audited financial statements for the quarter ended June 30, 2026. The documents are available on the company's website.
Persistent Systems was ranked 13th in the Hurun India Impact 50 - 2026 list. This recognition highlights the company's strong ESG performance and sustainable business practices.
Persistent Systems submitted its Annual Secretarial Compliance Report for FY 2025-26. The report confirms overall regulatory adherence with satisfactory remedial actions for previous minor delays.
Persistent Systems cancelled its June 4, 2026, analyst session, rescheduling it for June 5. Management will reiterate existing quarterly information with no new price-sensitive data.
Persistent Systems was named 2026 Google Cloud Partner of the Year for supply chain transformation. The recognition highlights Persistent's expertise in AI-led modernization and cloud-native solutions.
Persistent Systems earned 'Most Honored Company' status in Extel's 2026 Asia Executive Team survey. CEO Sandeep Kalra and the IR program both secured first-place rankings.
Persistent Systems has achieved the Databricks Brickbuilder Specialization for Healthcare & Life Sciences. This recognition validates Persistent's expertise in delivering production-ready AI and data solutions on the Databricks platform for regulated industries. The specialization strengthens Persistent's position in the healthcare, pharmaceutical, and medical device sectors.